← Back to Discover
Avidity Partners Management LP
Period ended Jun 30, 2026 · Latest filing Aug 14, 2026
These quarterly holdings are delayed and may not include all assets or short positions.
Values are from the reporting date, not current prices or purchase costs.
The same security may appear in multiple rows.
Source: SEC
Reported portfolio value
Quarter-end reported holdings; not current value or investment performance.
View reported values
- Jun 30, 2026: $624,441,478
More quarters will appear as history becomes available.
Top holdings
Top 10 at Jun 30, 2026. Matching entries are combined; security classes and options remain separate. Shares exclude principal amounts; option shares reflect the reported underlying amount.
View top holdings values
- DIANTHUS THERAPEUTICS INC · COM · 252828108 · shares: $205,115,856
- CG ONCOLOGY INC · COM · 156944100 · shares: $99,395,255
- ORUKA THERAPEUTICS INC · COM · 687604108 · shares: $72,369,552
- JADE BIOSCIENCES INC · COM NEW · 008064206 · shares: $37,789,732
- ENLIVEN THERAPEUTICS INC · COM · 29337E102 · shares: $27,912,500
- PERSPECTIVE THERAPEUTICS INC · COM NEW · 46489V302 · shares: $21,482,997
- AKTIS ONCOLOGY INC · COM · 01021M104 · shares: $15,605,766
- PALVELLA THERAPEUTICS INC NE · COM · 697947109 · shares: $10,697,400
- MOBIA MED INC · COMMON STOCK · 60705V103 · shares: $10,696,979
- REPLIGEN CORP · COM · 759916109 · shares: $10,615,032
Reported holdings
45 reported entries| Issuer | Class | CUSIP | Type | Shares / principal | Reported value (USD) |
|---|---|---|---|---|---|
| DIANTHUS THERAPEUTICS INC | COM | 252828108 | — | 2,104,184 shares | $205,115,856 |
| CG ONCOLOGY INC | COM | 156944100 | — | 1,398,948 shares | $99,395,255 |
| ORUKA THERAPEUTICS INC | COM | 687604108 | — | 760,424 shares | $72,369,552 |
| JADE BIOSCIENCES INC | COM NEW | 008064206 | — | 1,700,708 shares | $37,789,732 |
| ENLIVEN THERAPEUTICS INC | COM | 29337E102 | — | 550,000 shares | $27,912,500 |
| PERSPECTIVE THERAPEUTICS INC | COM NEW | 46489V302 | — | 6,299,999 shares | $21,482,997 |
| AKTIS ONCOLOGY INC | COM | 01021M104 | — | 484,200 shares | $15,605,766 |
| PALVELLA THERAPEUTICS INC NE | COM | 697947109 | — | 70,000 shares | $10,697,400 |
| MOBIA MED INC | COMMON STOCK | 60705V103 | — | 798,282 shares | $10,696,979 |
| REPLIGEN CORP | COM | 759916109 | — | 77,800 shares | $10,615,032 |
| IMMUNIC INC | COM NEW | 4525EP200 | — | 669,941 shares | $10,296,993 |
| SENSEONICS HLDGS INC | COM | 81727U303 | — | 1,600,000 shares | $9,088,000 |
| KARYOPHARM THERAPEUTICS INC | COM NEW | 48576U205 | — | 924,487 shares | $9,032,238 |
| TEVA PHARMACEUTICAL INDS LTD | SPONSORED ADS | 881624209 | — | 200,000 shares | $6,776,000 |
| DEXCOM INC | COM | 252131107 | — | 100,000 shares | $6,735,000 |
| TEMPUS AI INC | CL A | 88023B103 | — | 105,000 shares | $6,082,650 |
| MEDTRONIC PLC | SHS | G5960L103 | — | 70,000 shares | $5,476,100 |
| VIR BIOTECHNOLOGY INC | COM | 92764N102 | — | 519,300 shares | $5,291,667 |
| STRUCTURE THERAPEUTICS INC | SPONSORED ADS | 86366E106 | — | 98,000 shares | $5,259,660 |
| ENCOMPASS HEALTH CORP | COM | 29261A100 | — | 42,000 shares | $4,245,360 |
| TENAX THERAPEUTICS INC | COM NEW | 88032L605 | — | 265,934 shares | $3,869,340 |
| NUVECTIS PHARMA INC | COM | 67080T108 | — | 200,000 shares | $3,678,000 |
| INSULET CORP | COM | 45784P101 | — | 24,000 shares | $3,654,000 |
| BOSTON SCIENTIFIC CORP | COM | 101137107 | — | 80,000 shares | $3,414,400 |
| SATELLOS BIOSCIENCE INC | COM | 80401L803 | — | 387,769 shares | $3,014,904 |
| ALAMAR BIOSCIENCES INC | COMMON STOCK | 010911105 | — | 110,000 shares | $2,979,900 |
| CONTEXT THERAPEUTICS INC | COM | 21077P108 | — | 4,998,267 shares | $2,768,540 |
| GILEAD SCIENCES INC | COM | 375558103 | — | 20,000 shares | $2,526,800 |
| CHARLES RIV LABS INTL INC | COM | 159864107 | — | 10,000 shares | $2,267,900 |
| PHATHOM PHARMACEUTICALS INC | COM | 71722W107 | — | 200,000 shares | $2,170,000 |
| AVALYN PHARMACEUTICALS INC | COM SHS | 05348Y105 | — | 60,000 shares | $1,975,200 |
| KAILERA THERAPEUTICS INC | COMMON STOCK | 482931102 | — | 80,000 shares | $1,762,400 |
| GENMAB A/S | SPONSORED ADS | 372303206 | — | 50,000 shares | $1,373,500 |
| INTELLIA THERAPEUTICS INC | COM | 45826J105 | — | 75,000 shares | $1,269,000 |
| CORVUS PHARMACEUTICALS INC | COM | 221015100 | — | 80,000 shares | $1,195,200 |
| ODDITY TECH LTD | SHS CL A | M7518J104 | — | 70,000 shares | $1,059,100 |
| SCYNEXIS INC | COM | 811292309 | — | 260,206 shares | $1,059,038 |
| EVOMMUNE INC | COM SHS | 30054Y107 | — | 75,000 shares | $996,750 |
| ABBOTT LABORATORIES | COM | 002824100 | — | 10,000 shares | $907,400 |
| BRIDGEBIO PHARMA INC | COM | 10806X102 | — | 10,000 shares | $744,800 |
| PELOTON INTERACTIVE INC | CL A COM | 70614W100 | — | 100,000 shares | $591,000 |
| LEGEND BIOTECH CORP | SPONSORED ADS | 52490G102 | — | 15,000 shares | $433,200 |
| BRIDGEBIO ONCOLOGY THERAPEUT | COM NEW | 107924102 | — | 43,853 shares | $334,160 |
| SAVARA INC | COM | 805111101 | — | 50,000 shares | $308,000 |
| TREVI THERAPEUTICS INC | COM | 89532M101 | — | 6,660 shares | $124,209 |